325172-48-3

Basic information

• Product Name: Benzoic acid, 2-methoxy-6-(2-propenyl)-, 2-propenyl ester
• CAS NO: 325172-48-3
• Molecular Formula: C14H16O3
• Molecular Weight: 232.279
• Mol File: 325172-48-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-methoxy-6-(2-propenyl)-, 2-propenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-methoxy-6-(2-propenyl)-, 2-propenyl ester(325172-48-3)
• EPA Substance Registry System: Benzoic acid, 2-methoxy-6-(2-propenyl)-, 2-propenyl ester(325172-48-3)

Safety Data

• Hazardous Substances Data: 325172-48-3(Hazardous Substances Data)

Upstream product

• 325172-47-2 2-hydroxy-6-(prop-2-enyl)benzoic acid allyl ester 
• 74-88-4 methyl iodide 
• 164014-40-8 2,2-dimethyl-5-trifluoromethylsulfonyloxy-4H-(1,3)benzodioxin-4-one 
• 204846-40-2 2,2-dimethyl-5-(2-propenyl)-4H-1,3-benzodioxin-4-one 

Downstream Products

• 325172-28-9 2-allyl-6-methoxy-benzoic acid 
• 320573-70-4 (3S,5R,6S,Z)-14-methoxy-3-(2-((4-methoxybenzyl)oxy)-ethyl)-5-(methoxymethoxy)-6-methyl-3,4,5,6,7,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-one 
• 198481-99-1 (-)-salicylihalamide A 
• 198482-00-7 (2Z,4E)-Hepta-2,4-dienoic acid [(E)-3-((E)-(7S,9R,10S)-4,9-dihydroxy-10-methyl-5-oxo-7,8,9,10,11,14-hexahydro-5H-6-oxa-benzocyclododecen-7-yl)-propenyl]-amide 
• 398478-58-5 (3S,5R,6S,E)-14-methoxy-3-(2-((4-methoxybenzyl)oxy)-ethyl)-5-(methoxymethoxy)-6-methyl-3,4,5,6,7,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-one 
• 398478-57-4 2-methoxy-6-(prop-2-enyl)benzoic acid (1S,3R,4S)-1-[2-(4-methoxybenzyloxy)ethyl]-3-methoxymethoxy-4-methylhept-6-enyl ester 
• 420794-45-2 2-methoxy-6-(prop-2-enyl)benzoic acid (1S,3S,4R)-3-(tert-butyldimethylsilyloxy)-1-[2-(tert-butyldimethylsilyloxy)ethyl]-4-methylhept-6-enyl ester 
• 398478-36-9 (12E)-(7S,9R,10S)-9-benzoyloxy-4-(tert-butyldimethylsilyloxy)-7-[(2E)-3-carboxyprop-2-enyl]-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclodecen-5-one 
• 398478-33-6 (12E)-(7S,9R,10S)-4-benzoyloxy-9-(tert-butyldimethylsilyloxy)-7-[(2E)-3-carboxyprop-2-enyl]-10-methyl-7,8,9,10,11,14-hexahydro-6-oxabenzocyclodecen-5-one 
• 398478-34-7 (12E)-(7S,9R,10S)-7-[(2E)-4-azido-4-oxo-but-2-enyl]-4-benzoyloxy-9-(tert-butyldimethylsilyloxy)-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclodecen-5-one 
• 398478-37-0 (12E)-(7S,9R,10S)-7-[(2E)-4-azido-4-oxo-but-2-enyl]-9-benzoyloxy-4-(tert-butyldimethylsilyloxy)-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclodecen-5-one 
• 398478-73-4 (12E)-(7S,9R,10S)-9-benzoyloxy-4-(tert-butyldimethylsilyloxy)-7-[(2E)-3-(carboallyloxy)prop-2-enyl]-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclodecen-5-one 
• 398478-72-3 (12E)-(7S,9R,10S)-4-benzoyloxy-9-(tert-butyldimethylsilyloxy)-7-[(2E)-3-(carboallyloxy)prop-2-enyl]-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclodecen-5-one 
• 198482-00-7 (+)-Salicylihalamide A 

Relevant articles and documents

Revision of the absolute configuration of salicylihalamide A through asymmetric total synthesis

A highly E-selective ring-closing metathesis is the key to building the macrocyclic salicylate core of (+)-salicylihalamide A (1). The synthesis results in a reassignment of the absolute configuration of natural (-)-salicylihalamide A (2), a structurally